Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /calendar/action~posterboard/ Disallow: /calendar/action~agenda/ Disallow: /calendar/action~oneday/ Disallow: /calendar/action~month/ Disallow: /calendar/action~week/ Disallow: /calendar/action~stream/ Disallow: /calendar/action~undefined/ Disallow: /calendar/action~http:/ Disallow: /calendar/action~default/ Disallow: /calendar/action~poster/ Disallow: /calendar/action~*/ Disallow: /*controller=ai1ec_exporter_controller* Disallow: /*/action~*/ Disallow: /conferences/action~posterboard/ Disallow: /conferences/action~agenda/ Disallow: /conferences/action~oneday/ Disallow: /conferences/action~month/ Disallow: /conferences/action~week/ Disallow: /conferences/action~stream/ Disallow: /conferences/action~undefined/ Disallow: /conferences/action~http:/ Disallow: /conferences/action~default/ Disallow: /conferences/action~poster/ Disallow: /conferences/action~*/ Disallow: /calendar-2/action~posterboard/ Disallow: /calendar-2/action~agenda/ Disallow: |
Title | Home | Envol |
Description | Innovators in Translational Pharmacology and Envol Biomedical offers primate pk studies, primate toxicology studies, & primate pd studies. Species include Cynomolgus Monkeys & Rhesus |
Keywords | N/A |
WebSite | envolbio.com |
Host IP | 104.21.68.190 |
Location | United States |
Site | Rank |
US$2,803,374
Last updated: 2023-05-11 06:13:11
envolbio.com has Semrush global rank of 3,775,559. envolbio.com has an estimated worth of US$ 2,803,374, based on its estimated Ads revenue. envolbio.com receives approximately 323,467 unique visitors each day. Its web server is located in United States, with IP address 104.21.68.190. According to SiteAdvisor, envolbio.com is safe to visit. |
Purchase/Sale Value | US$2,803,374 |
Daily Ads Revenue | US$2,588 |
Monthly Ads Revenue | US$77,632 |
Yearly Ads Revenue | US$931,583 |
Daily Unique Visitors | 21,565 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
envolbio.com. | A | 299 | IP: 104.21.68.190 |
envolbio.com. | A | 299 | IP: 172.67.198.8 |
envolbio.com. | AAAA | 299 | IPV6: 2606:4700:3030::ac43:c608 |
envolbio.com. | AAAA | 299 | IPV6: 2606:4700:3033::6815:44be |
envolbio.com. | NS | 86400 | NS Record: dell.ns.cloudflare.com. |
envolbio.com. | NS | 86400 | NS Record: art.ns.cloudflare.com. |
envolbio.com. | MX | 300 | MX Record: 0 envolbio-com.mail.protection.outlook.com. |
envolbio.com. | TXT | 300 | TXT Record: ca3-89c8a0d72358429e80eff8f3a29a44b0 |
envolbio.com. | TXT | 300 | TXT Record: MS=ms75296970 |
envolbio.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
833-757-8839 833-PKSTUDY [email protected] Mon - Fri: 9:00 - 18:30 ABOUT CAPABILITIES Pharmacokinetics Pharmacodynamics Toxicology Immunopharmacology and immunotoxicology Inflammatory diseases In vitro pharmacology and toxicity Clinical laboratory support Gene Therapy Metabolic diseases REQUEST QUOTE PUBLICATIONS CONFERENCES CONTACT ABOUT CAPABILITIES Pharmacokinetics Pharmacodynamics Toxicology In vitro pharmacology and toxicity Clinical laboratory support Gene Therapy Immunopharmacology and immunotoxicology Metabolic diseases Inflammatory diseases REQUEST QUOTE PUBLICATIONS CONFERENCES CONTACT Menu ABOUT CAPABILITIES Pharmacokinetics Pharmacodynamics Toxicology In vitro pharmacology and toxicity Clinical laboratory support Gene Therapy Immunopharmacology and immunotoxicology Metabolic diseases Inflammatory diseases REQUEST QUOTE PUBLICATIONS CONFERENCES CONTACT Innovators in Translational Pharmacology and Toxicology Translating Molecules into Therapeutics: Center of Excellence in |
HTTP/1.1 301 Moved Permanently Date: Thu, 04 Nov 2021 05:32:23 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive swift-performance: MISS x-pingback: http://www.envolbio.com/xmlrpc.php x-redirect-by: WordPress location: https://www.envolbio.com/ cache-control: max-age=0 expires: Thu, 04 Nov 2021 03:26:09 GMT age: 7574 x-cache: HIT CF-Cache-Status: DYNAMIC Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=du9jahIGJN9Mp%2FViS%2BLWuC7O%2BlXaXhw23GKRkjHIIyWUyVVK5KHHUvmuOi%2FhNdP38rXZY8Sin5tkecl4fmwAgQBJvyMll2l2wJ8bWz4Mns2LbyiPKRF5%2Bv%2BXmO%2FgNYY%3D"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} Server: cloudflare CF-RAY: 6a8b76275d5c2c64-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 HTTP/2 200 date: Thu, 04 Nov 2021 05:32:23 GMT content-type: text/html last-modified: Wed, 18 Aug 2021 07:18:27 GMT vary: Accept-Encoding cache-control: max-age=0 expires: Thu, 04 Nov 2021 04:35:12 GMT age: 3430 x-cache: HIT cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=7tQV2DDAhrwgGN1%2BXaIBOYsFq3THDacN9AfGgrZHK1vuwLy0IBQkilSGgX8fRe1nUyosl94OGdEmUhGFFaH%2BuskC%2FE1mNKjYTt2HTI4RYSmdeCx2c%2F9U8lcrwkE6kPTf%2ByqD"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 6a8b76280fdc2c88-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 |
Domain Name: ENVOLBIO.COM Registry Domain ID: 2343988537_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.1api.net Registrar URL: http://www.1api.net Updated Date: 2021-12-17T08:28:27Z Creation Date: 2018-12-16T19:53:11Z Registry Expiry Date: 2022-12-16T19:53:11Z Registrar: 1API GmbH Registrar IANA ID: 1387 Registrar Abuse Contact Email: abuse@1api.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: ART.NS.CLOUDFLARE.COM Name Server: DELL.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-22T08:34:58Z <<< |